Premier Alternatives

Enable Injections

Cincinnati, OH · Founded 2010 · Privately Held (backing)

Operator of a healthcare innovation company intended to improve the patient treatment experience through the development of wearable drug delivery products. Enable Injections is based in Cincinnati, OH and was founded in 2010. It was valued at $930 million at its later-stage round in Jan 2026, the last priced event on record. It has raised $342 million across 7 recorded rounds; the latest was a $30 million early-stage round in Dec 2025.

PMV mark · valuation
$930.0M
Oct 2026
Priced at
its later-stage round
Jan 2026
Total raised
$341.7M
Last round
Early Stage VC
Dec 2025

Enable Injections key facts

as of Oct 2026
  • Operator of a healthcare innovation company intended to improve the patient treatment experience through the development of wearable drug delivery products.
  • Enable Injections is valued at approximately $930.0M as of Oct 2026, set at its later-stage round, Jan 2026; nothing has traded since, per PrivateMarketView’s mark.
  • It has raised $341.7M across 7 recorded rounds; the latest was Early Stage VC ($30.0M) in Dec 2025.
  • Notable investors include Cintrifuse Capital, Magnetar Capital, CincyTech, Squarepoint Capital, Cincinnati Children's Hospital Medical Center — 14 tracked in total.
  • Enable Injections has filed 16 Form Ds with the SEC since 2014, most recently Feb 2022 ($150.0M sold to 22 investors).
  • Status: Privately Held (backing).
PrivateMarketView mark
MEDIUM confidence
$930.0M

Valued at $930.0M at its later-stage round, Jan 2026. Nothing has traded since.

set by its last priced roundas of Oct 2026question about this number?
Free account
More of Enable Injections with a free account
  • ·The complete investor list: 14 names
  • ·Watch Enable Injections: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Enable Injections funding rounds

7 rounds
Dec 2025Early Stage VC$30.0MSEC filing▮
Jan 2022Later Stage VC$150.0MSEC filing▮
Oct 2018Early Stage VC$30.7MSEC filing▮
Aug 2016Early Stage VC$25.0MSEC filing▮
Jun 2016Early Stage VC$5.0MSEC filing▮
Full funding history →

Enable Injections valuation

Enable Injections was valued at $930 million at its later-stage round in Jan 2026. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Enable Injections raised?

Enable Injections has raised $342 million across 7 recorded rounds since 2012. The largest was a $5 million early-stage round in Jun 2016; the most recent was a $30 million early-stage round in Dec 2025.

Enable Injections has filed 16 Form Ds with the SEC since 2014, most recently in Feb 2022 ($150 million sold to 22 investors).

Enable Injections investors

14 investors are on record for Enable Injections, including Cintrifuse Capital, Magnetar Capital, CincyTech and Squarepoint Capital. The early-stage round in Dec 2025 drew 1 investor.

About Enable Injections

Operator of a healthcare innovation company intended to improve the patient treatment experience through the development of wearable drug delivery products. The company's devices are high-volume injectors that utilize any standard container closure system, including a syringe, vial, or cartridge, enabling patients to easily, comfortably, and control self-administration.

Sector
Healthcare
HQ
Cincinnati, OH, United States
Founded
2010
Employees
193
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.